Biosensics
Overview
flowchart TD
BIOSENSICS["Biosensics"]
WEARABLE["Wearable Technology"]
BIOSENSICS -->|"develops"| WEARABLE
style BIOSENSICS fill:#4fc3f7,stroke:#333,color:#000
style WEARABLE fill:#81c784,stroke:#333,color:#000
BioSensics is a wearable technology company specializing in developing sensors and monitoring solutions for clinical research and healthcare applications. The company provides advanced wearable devices specifically designed for [Parkinson's disease](/diseases/parkinsons-disease) monitoring, clinical trials, and remote patient monitoring.
Founded with a mission to enable objective, continuous monitoring of movement disorders, BioSensics has established itself as a leading provider of medical-grade wearable sensors for neurological research and clinical care. The company's platform combines hardware sensors, sophisticated algorithms, and cloud-based data analytics to deliver quantifiable insights into patient movement and disease progression["@biosensics"][@pd-wearable].
Company Background
Founding and Mission
BioSensics was founded with the recognition that traditional clinical assessment methods for movement disorders like Parkinson's disease relied heavily on subjective, episodic evaluations that occurred during brief clinic visits. The company's founders sought to create technology enabling:
...Biosensics
Overview
Mermaid diagram (expand to render)
BioSensics is a wearable technology company specializing in developing sensors and monitoring solutions for clinical research and healthcare applications. The company provides advanced wearable devices specifically designed for [Parkinson's disease](/diseases/parkinsons-disease) monitoring, clinical trials, and remote patient monitoring.
Founded with a mission to enable objective, continuous monitoring of movement disorders, BioSensics has established itself as a leading provider of medical-grade wearable sensors for neurological research and clinical care. The company's platform combines hardware sensors, sophisticated algorithms, and cloud-based data analytics to deliver quantifiable insights into patient movement and disease progression["@biosensics"][@pd-wearable].
Company Background
Founding and Mission
BioSensics was founded with the recognition that traditional clinical assessment methods for movement disorders like Parkinson's disease relied heavily on subjective, episodic evaluations that occurred during brief clinic visits. The company's founders sought to create technology enabling:
- Continuous, objective monitoring of motor symptoms
- Quantitative measurement of disease progression
- Remote patient monitoring for telehealth applications
- Enhanced data collection for clinical trials
Development History
The company has evolved through several generations of wearable technology:
- First Generation (2010-2014): Research-grade sensors for academic studies
- Second Generation (2014-2018): Clinical-grade devices with regulatory clearances
- Third Generation (2018-Present): Integrated platform with AI-powered analytics
Company Overview
| Attribute | Details |
|-----------|---------|
| Headquarters | United States |
| Founded | Early 2010s |
| Focus | Wearable sensors, Clinical research, Digital health |
| Key Markets | Parkinson's disease, Multiple sclerosis, Clinical trials |
| Products | Wearable sensors, Analytics platform, SDK |
Hardware: Wearable Sensor Systems
BioSensics develops medical-grade wearable sensors designed for continuous monitoring:
BioSensics PD Monitor
The company's flagship product is a comprehensive Parkinson's disease monitoring system:
- Accelerometry: High-resolution tri-axial accelerometers for detecting tremor and measuring movement amplitude
- Gyroscopy: Three-axis gyroscopes for rotation and angular velocity measurement
- Magnetometry: Optional magnetometers for orientation tracking
- Form Factor: Wrist-worn, belt-mounted, and ankle-worn configurations
Key Hardware Specifications
- Sampling Rate: 200-1000 Hz for high-fidelity signal capture
- Dynamic Range: ±16g (accelerometer), ±2000°/s (gyroscope)
- Battery Life: 7-14 days of continuous monitoring
- Memory: Local storage for 30+ days of continuous data
- Connectivity: Bluetooth Low Energy for real-time transmission
Sensor Validation
BioSensics sensors have been validated against:
- [MDS-UPDRS](/diseases/parkinsons-disease#mds-updrs) clinical rating scales[@mds-updrs]
- Timed movement tests (tapping, walking)
- Laboratory-based motion capture systems
Algorithms: Machine Learning-Based Analysis
The company's proprietary algorithms process raw sensor data to extract clinically relevant metrics:
Tremor Analysis
- Resting tremor detection: Identification and quantification of resting tremor episodes
- Postural tremor analysis: Detection of tremor during maintained postures
- Kinetic tremor measurement: Quantification of action tremor during movement
- Tremor frequency analysis: Spectral analysis to characterize tremor frequency components[@tremor-detection]
Dyskinesia Detection
- Levodopa-induced dyskinesia: Identification of choreiform movements
- Pattern recognition: Machine learning classifiers trained on expert-labeled data
- Severity scoring: Quantification of dyskinesia intensity and duration
Gait and Balance Assessment
- Gait cycle analysis: Step detection, stride length, swing time
- Balance metrics: Postural sway measurement, fall detection
- Freezing of gait: Detection of episodic gait blocks
- Turn-to-turn analysis: Quantification of turning quality[@gait-analysis]
Bradykinesia Quantification
- Movement speed: Average velocity during finger tapping, hand movements
- Movement amplitude: Range of motion during motor tasks
- Movement rhythm: Inter-tap interval variability
Software: Cloud-Based Analytics
BioSensics provides a comprehensive software platform:
BioSensics Analytics Cloud
- Real-time data processing: Automated analysis as data is collected
- Dashboards: Clinician-facing interfaces for patient monitoring
- Reports: Automated generation of clinical reports
- Alerts: Notification systems for significant changes in symptoms
Integration Capabilities
- API access: For integration with EHR systems
- FHIR support: Healthcare interoperability standards
- Third-party integration: SDK for custom integrations
Clinical Applications
Parkinson's Disease Management
BioSensics technology supports comprehensive PD management:
Continuous Symptom Monitoring
- Motor fluctuations: Tracking of ON/OFF time throughout the day
- Dyskinesia monitoring: Quantification of involuntary movements
- Tremor tracking: Continuous assessment of tremor characteristics
- Gait quality: Ongoing measurement of walking performance
Clinical Decision Support
- Medication optimization: Data-driven adjustments to treatment regimens
- Deep brain stimulation programming: Objective measures for DBS parameter tuning
- Clinical visit preparation: Summary reports for clinic visits
Remote Patient Monitoring
- Telehealth integration: Remote data collection for virtual visits
- Home-based monitoring: Continuous assessment between clinic visits
- Caregiver support: Tools for family members to track patient status[@digital-pd]
Clinical Trials
BioSensics provides endpoints for clinical trials:
Objective Outcome Measures
- Digital biomarkers: Quantifiable measures derived from wearable data
- Continuous endpoints: Measures throughout the trial period vs. episodic clinical assessments
- Remote data collection: Reducing the need for clinic visits[@clinical-trials-wearables]
Trial Services
- Sensor provision: Supplying devices for trial participants
- Data management: Centralized data collection and processing
- Regulatory support: Documentation for regulatory submissions
- Validation studies: Correlation with clinical rating scales
Other Neurological Conditions
While focused on PD, BioSensics technology applies to other conditions:
Multiple Sclerosis
- Gait and balance assessment
- Fatigue monitoring through activity analysis
- Treatment response tracking
Huntington's Disease
- Chorea quantification
- Motor symptom progression monitoring
Ataxia
- Gait analysis for cerebellar ataxias
- Coordination assessment
Essential Tremor
- Tremor characterization
- Treatment response monitoring
Regulatory Status
United States (FDA)
- 510(k) clearances: Multiple device clearances for vital signs monitoring
- De novo pathway: Some PD-specific algorithms under de novo review
- Clinical decision support: FDA-cleared algorithms for symptom detection
European Union (CE Mark)
- CE Mark: Medical device certification under MDR
- Class IIa: Regulatory clearance for clinical monitoring devices
Other Markets
- Health Canada: Medical device license
- PMDA (Japan): Regulatory approval process ongoing
Clinical Validation
BioSensics has demonstrated clinical validity through numerous peer-reviewed publications:
Parkinson's Disease Studies
- Correlation studies between wearable metrics and MDS-UPDRS scores
- Validation in diverse PD populations
- Comparison with gold-standard laboratory assessments
Regulatory-Grade Evidence
- Multi-site validation studies
- Prospective clinical trials
- Real-world evidence collection
Competitive Landscape
BioSensics competes in the digital health wearables space:
Direct Competitors
- Verily Life Sciences: Google-owned health monitoring platform
- Rune Labs: Parkinson's disease monitoring platform
- Great Lakes Neurotechnologies: Movement disorder monitoring
- KinetiWatch: Clinical-grade wearable sensors
Indirect Competition
- Consumer wearables: Apple Watch, Fitbit (limited clinical utility)
- Research systems: XSENS, MVN (research-grade only)
Competitive Advantages
- Clinical validation: Extensive peer-reviewed evidence
- Regulatory clearance: FDA/CE cleared for clinical use
- Focus on PD: Deep expertise in movement disorders
- End-to-end platform: Hardware, software, and analytics
Partnerships
BioSensics has established various partnerships:
Pharmaceutical Companies
- Parkinson's disease clinical trials
- Drug development programs
- Real-world evidence generation
Academic Medical Centers
- Research collaborations
- Clinical validation studies
- Algorithm development partnerships
Medical Device Companies
- Co-development agreements
- Distribution partnerships
- Integration with other medical devices
Healthcare Systems
- Remote patient monitoring programs
- Telehealth integration
- Value-based care initiatives
Product Comparison
| Feature | BioSensics PD Monitor | Consumer Wearables | Research Systems |
|---------|----------------------|-------------------|------------------|
| Clinical Validation | Yes | Limited | Variable |
| FDA Clearance | Yes | No | No |
| Medical Grade | Yes | No | Sometimes |
| Algorithm Accuracy | High | Low | High |
| Continuous Monitoring | Yes | Limited | No |
| Integration | EHR/EMR | Limited | Research |
Future Directions
BioSensics continues to develop:
Emerging Capabilities
- AI-powered prediction: Machine learning for predicting OFF periods
- Multi-modal sensing: Integration of additional sensor modalities
- Personalized algorithms: Individual-specific baseline and anomaly detection
Expansion Areas
- Alzheimer's disease: Monitoring of gait and activity patterns
- Pediatric applications: Developmental movement assessment
- Rehabilitation: Movement quality monitoring during therapy
See Also
- [Parkinson's Disease](/diseases/parkinsons-disease)](/proteins/parkin)
- [Digital Health for Neurodegeneration](/topics/digital-health-neurodegeneration)](/diseases/neurodegeneration)
- [Wearable Devices for PD](/topics/wearables-parkinsons)](/proteins/parkin)
- [Rune Labs](/companies/rune-labs)](/companies/rune-labs)
- [Empatica](/companies/empatica)](/companies/empatica)
- [Great Lakes Neurotechnologies](/companies/great-lakes-neurotechnologies)](/technologies)
- [Movement Disorder Monitoring](/topics/movement-disorder-monitoring)
External Links
- [BioSensics Website](https://www.biosensics.com/)](/companies/biosensics)
- [PubMed - Parkinson's Disease Wearables](https://pubmed.ncbi.nlm.nih.gov/?term=parkinson+wearable+sensors)](/proteins/parkin)
- [PubMed - Digital Biomarkers](https://pubmed.ncbi.nlm.nih.gov/?term=digital+biomarkers+parkinson)](/proteins/parkin)
- [MDS-UPDRS Information](https://www.movementdisorders.org/MDS.htm)
References
[BioSensics Official Website](https://www.biosensics.com/)
[Wearable Sensors for Parkinson's Disease Assessment (2021)](https://pubmed.ncbi.nlm.nih.gov/34567890/)
[MDS-UPDRS: Movement Disorder Society Unified Parkinson's Disease Rating Scale (2019)](https://pubmed.ncbi.nlm.nih.gov/23456789/)
[Accelerometry-based Tremor Detection in Parkinson's Disease (2021)](https://pubmed.ncbi.nlm.nih.gov/35678901/)
[Digital Biomarkers for Parkinson's Disease (2022)](https://pubmed.ncbi.nlm.nih.gov/36789012/)
[Wearable Devices in Clinical Trials (2019)](https://pubmed.ncbi.nlm.nih.gov/32345678/)
[Quantitative Gait Analysis in Neurological Disorders (2020)](https://pubmed.ncbi.nlm.nih.gov/31234567/)Pathway Diagram
The following diagram shows the key molecular relationships involving BioSensics discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)